Talphera (TLPH) Change in Account Payables (2010 - 2026)
Talphera (TLPH) posted quarterly Change in Account Payables of $210000.0 for Q1 2026, up 160.87% year-over-year from $80500.0 in Q1 2025, and up 125.81% quarter-over-quarter from $93000.0 in Q4 2025.
Talphera (TLPH) Change in Account Payables (2010 - 2026) Analysis & Trends
Talphera's Change in Account Payables history runs 17 years deep, the most recent figure standing at $210000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 160.87% year-over-year to $210000.0; the TTM figure through Mar 2026 stood at $347000.0 (up 136.37% YoY), while the FY2025 annual figure was -$208000.0, up 69.0% from the prior year.
- Change in Account Payables for Q1 2026 stood at $210000.0, up from $93000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $526000.0 in Q4 2022, with the low at -$774000.0 in Q2 2023.
- The 5-year median for Change in Account Payables is $37000.0 (2022), against an average of -$40764.7.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables soared 409.41% in 2022, then sank 2191.89% in 2023.
- Talphera's Change in Account Payables stood at $526000.0 in 2022, then fell by 27.38% to $382000.0 in 2023, then fell by 28.27% to $274000.0 in 2024, then slumped by 66.06% to $93000.0 in 2025, then soared by 125.81% to $210000.0 in 2026.
- Business Quant data shows TLPH's Change in Account Payables at $210000.0 in Q1 2026, $93000.0 in Q4 2025, and -$466000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Talphera | 89.88 Mn | 89.88 Mn | - | -366,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -366,000.00 |
| Jun 30, 2026 | -366,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Mar 31, 2024 | -62,000.00 |